RCMNY
RVNC

Rubric Capital Management (New York)’s Revance Therapeutics, Inc. RVNC Stock Holding History

Rubric Capital Management (New York)’s Portfolio RVNC Stock Details RVNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,656,847
Closed -$6.83M – 77
2024
Q2 		$6.83M Hold
2,656,847
– – 0.18% 58
2024
Q1 		$13.1M Buy
2,656,847
+1,195,373
+82% +$7.08M 0.39% 54
2023
Q4 		$12.8M Sell
1,461,474
-138,526
-9% -$1.13M 0.48% 45
2023
Q3 		$18.4M Buy
+1,600,000
New +$30.8M 0.77% 37

Other funds holding RVNC

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.83B AUM 190.64% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
WIC
Water Island Capital New York $750M AUM 107.59% 1-Year Est. Return